NIH’s efforts on long Covid draw patient, expert ire; second booster authorized for people 50 and up

More than 15 months ago, the NIH got over $1 billion to study long Covid. But so far it's brought in just 3% of the patients it plans to. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        'A slow-moving glacier': NIH's sluggish and often opaque efforts to study long Covid draw patient, expert ire By Rachel Cohrs Molly Ferguson for STAT More than 15 months ago, the NIH got over $1 billion to study long Covid. But so far it's brought in just 3% of the patients it plans to. Read More U.S. approves second Covid-19 booster for people 50 and older By Andrew Joseph Eugene Hoshiko/AP Those 50 and up are now eligible for another shot of either the Pfizer-BioNTech and Moderna mRNA vaccines four months after their last dose. Read More STAT+: UnitedHealth's deal with LHC highlights broader interest in home health industry By Bob Herman and Tara Bannow Jim Mone/AP UnitedHealth Group’s proposed $5.4 billion buyout of home health provider LHC Group shows insurers' ravenous appetite for the sector. Read More Sponsor content by THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER The James P. Allison Institute — Ushering in a new era for immunotherapy MD Anderson is proud to announce the launch of the James P. Allison Institute, a visionary research and innovation hub within the nation's No. 1 hospital for cancer care designed to foster groundbreaking science, to develop new treatments and to bring the benefits of immunotherapy to all patients. The institute's vision is to lead the world in immunotherapy research by empowering interdisciplinary scientific excellence by accelerating discoveries into novel and synergetic therapies that enable cures. Learn more about the Allison Institute at MD Anderson. Covid-19 pandemic isn't over for Black Americans, report warns By Usha Lee McFarling JOSEPH PREZIOSO/AFP via Getty Images In January, the Covid-19 hospitalization rate for Black people was higher than it had been at any time during the pandemic. Read More STAT+: Lawmakers and a Pelosi aide turn lobbyist to push for new health agency's independence By Lev Facher Rich Pedroncell/AP Xavier Becerra is the focus of a frenzied, last-minute lobbying effort from top lawmakers and a key Nancy Pelosi aide on ARPA-H. Read More Afghan refugees, grappling with grief and trauma, face barriers to mental health care By Grace Deng and Jenny Jiin Huh Courtesy Aryan Fardeen Families that fled Afghanistan and resettled in the U.S. are grappling with grief and depression, but struggle to access care. Read More STAT+: Inflation caused 'unprecedented' drops in net pharmaceutical prices, analysis finds By Ed Silverman Adobe A new analysis finds that after accounting for inflation, wholesale prices of brand-name drugs fell by 2.3% in the last quarter of 2021. Read More Opinion: How to fix the two-tier U.S. health payment system By Amol Navathe and Risa Lavizzo-Mourey and Joshua Liao Adobe To level its two-tiered system of health care, the U.S. needs to fundamentally revamp its health payment system. Read More Tuesday, March 29, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser